Pharming Group N.V. (PHAR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 1.63M | 7.39M | 30.01M | 11.74M | 232K | 9.33M | 9.7M | -13.17M | -7.65M | 11.58M | 3.53M | -9.62M |
| Operating CF Margin % | 2.24% | 0.01% | 30.85% | 12.6% | 0.29% | 10.07% | 12.97% | -17.79% | -13.76% | 14.25% | 5.29% | -17.53% |
| Operating CF Growth % | 601.25% | -20.8% | 209.24% | 189.14% | 103.03% | -19.4% | 175.15% | -36.92% | 66.44% | 104.04% | -72.04% | -340.65% |
| Net Income | -5.23M | 5.29M | 7.47M | 7.08M | -11.79M | 6.68M | -1.04M | -1.2M | -16.62M | -2.03M | 3.31M | 3.39M |
| Depreciation & Amortization | 3.13M | 0 | 2.71M | 2.7M | 2.58M | 7.7M | 2.75M | 0 | 5.92M | 7.55M | 2.9M | 3.16M |
| Stock-Based Compensation | 0 | 0 | 0 | 3.48M | 2.58M | 2.64M | 0 | 0 | 2.43M | 3.32M | 1.97M | 2.41M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.62M | -174K | 10.8M | -124K | 5.44M | -604K | 659.34K | -2.73M | 1.68M | 4.12M | -83K | -19.78M |
| Working Capital Changes | 114.41K | 2.27M | 9.03M | -1.39M | 1.42M | -7.08M | 7.33M | -9.24M | -1.05M | -1.38M | -4.56M | 1.2M |
| Change in Receivables | -4.41M | -14.86M | 9.12M | -3.03M | 5.38M | -4.74M | 2.91M | -12.4M | 7.46M | -5.64M | -7.36M | -226K |
| Change in Inventory | -264.96K | 2.22M | -3.21M | 774K | -1.08M | 4.75M | -2.14M | -3.99M | 877K | -3.32M | -396K | -4.92M |
| Change in Payables | 5.3M | 13.72M | 3.12M | 0 | 0 | 0 | 6.55M | 7.14M | 0 | 0 | 0 | 0 |
| Cash from Investing | -85.07M | -63.81K | -2.34M | 16.95M | 9.69M | -9.79M | 4.39M | 36.34M | 664K | -3.91M | -58.23M | 20.31M |
| Capital Expenditures | -238.87K | -269.25K | -68.67K | -128K | -288K | -136K | -366.15K | -213.73K | -80K | -331K | -147K | -771K |
| CapEx % of Revenue | 0.33% | 0% | 0.07% | 0.14% | 0.36% | 0.15% | 0.49% | 0.29% | 0.14% | 0.41% | 0.22% | 1.4% |
| Acquisitions | 0 | 66.3K | -1.67M | -18K | -57.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 139.15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 176K | 23K | 21.08M |
| Cash from Financing | -9.26M | 3.6M | 11.95M | -2.76M | -6.72M | -2.2M | -1.46M | -28.27M | -2.47M | -1.02M | 5.24M | -2.63M |
| Debt Issued (Net) | 0 | 0 | 0 | -1.07M | -715K | -1.52M | -304.62K | -30.07M | -1.03M | -1.28M | -1.01M | -1.26M |
| Equity Issued (Net) | 3.89M | 5.25M | 13.33M | 0 | 0 | 0 | 26.75K | 2.57M | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -13.15M | -1.65M | -1.38M | -1.69M | -6M | -688K | -1.18M | -768.84K | -1.44M | 259K | 6.25M | -1.37M |
| Net Change in Cash | -92.96M | 13M | 38.24M | 32M | 5.15M | -5.72M | 13.52M | -4.75M | -9.85M | 7.09M | -50.37M | 7.59M |
| Free Cash Flow | 1.39M | 7.12M | 29.94M | 11.62M | -56K | 9.2M | 9.34M | -13.39M | -7.73M | 11.25M | 3.38M | -10.39M |
| FCF Margin % | 1.91% | 0.01% | 30.78% | 12.46% | -0.07% | 9.92% | 12.48% | -18.08% | -13.9% | 13.85% | 5.07% | -18.93% |
| FCF Growth % | 2578.63% | -22.55% | 220.63% | 186.76% | 99.28% | -18.24% | 176.28% | -28.82% | 66.4% | 109.85% | -72.99% | -469.17% |
| FCF per Share | 0.02 | 0.09 | 0.45 | 0.17 | -0.00 | 0.14 | 0.14 | -0.16 | -0.09 | 0.13 | 0.04 | -0.16 |
| FCF Conversion (FCF/Net Income) | -0.31x | 0.00x | 3.98x | 2.50x | -0.02x | 3.26x | -9.39x | 10.99x | 0.61x | -3.71x | 1.02x | -7.29x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |